Interactions between nanoparticles and pathological changes of vascular in Alzheimer's disease

Adv Drug Deliv Rev. 2024 Feb 22:115219. doi: 10.1016/j.addr.2024.115219. Online ahead of print.ABSTRACTEmerging evidence suggests that vascular pathological changes play a pivotal role in the pathogenesis of Alzheimer's disease (AD). The dysfunction of the cerebral vasculature occurs in the early course of AD, characterized by alterations in vascular morphology, diminished cerebral blood flow (CBF), impairment of the neurovascular unit (NVU), vasculature inflammation, and cerebral amyloid angiopathy. Vascular dysfunction not only facilitates the influx of neurotoxic substances into the brain, triggering inflammation and immune responses but also hampers the efflux of toxic proteins such as Aβ from the brain, thereby contributing to neurodegenerative changes in AD. Furthermore, these vascular changes significantly impact drug delivery and distribution within the brain. Therefore, developing targeted delivery systems or therapeutic strategies based on vascular alterations may potentially represent a novel breakthrough in AD treatment. This review comprehensively examines various aspects of vascular alterations in AD and outlines the current interactions between nanoparticles and pathological changes of vascular.PMID:38401847 | DOI:10.1016/j.addr.2024.115219
Source: Advanced Drug Delivery Reviews - Category: Drugs & Pharmacology Authors: Source Type: research